loader
Please Wait
Applying Filters...

Quality Alerts: Health Canada Recalls Hoffmann-La Roche's Casirivimab and Imdevimab – High Risk of Treatment Failure Due to Circulation of SARS-CoV-2 Omicron Variant - F. Hoffmann-la Roche

Xls
Menu